Meclizine Hydrochloride 12.5 mg tablets recalled for failed specifications
American Health Packaging is recalling specific batches of Meclizine Hydrochloride 12.5 mg tablets because they failed to meet required tablet specifications. The affected product is Lot #1024852 with an expiration date of 9/30/2026. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Amerisource recalls
What to do
- Check if you have Meclizine Hydrochloride tablets with Lot #1024852 and expiration 9/30/2026
- Do not use the recalled tablets
- Contact your pharmacy or prescriber for a replacement or alternative medication
- Return the recalled medication to your pharmacy
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 697 cartons
- Illnesses reported
- None reported
- Manufactured in
- 2550 John Glenn Ave Ste A, Columbus, OH, United States
- Classification
- Class II
- Recall number
- D-0418-2026
In the FDA's words
- Description
- Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217. Failed tablet specifications. Lot #1024852; Exp 9/30/2026 Distribution: U.S. Nationwide Affected quantity: 697 cartons
- Hazard
- Failed tablet specifications.